EU Wants Genzyme To Make "Robust" Manufacturing Changes
This article was originally published in The Pink Sheet Daily
Executive Summary
EU's top advisory committee, the CHMP, wants a risk assessment of Genzyme's manufacturing and waits for further data from GSK and Sanofi on porcine virus contamination of rotavirus vaccines.